国际专家共识:肺癌合并慢性阻塞性肺疾病的诊断与治疗
该国际专家共识由肿瘤、呼吸、影像、介入和胸外科专家组成的小组制定,基于对肺癌合并慢性阻塞性肺疾病(LC-COPD)现有证据的全面回顾,经讨论后以超过70%的投票同意率达成17条推荐,涵盖发病机制、总体策略及在COPD和肺癌中的临床应用,强调以患者为中心的个体化治疗。
要点
- 共识提出17条推荐,涵盖发病机制、总体策略及COPD和肺癌的临床应用。
- 推荐强调对LC-COPD患者应同时治疗肺癌和COPD,并注意两者相互影响及不良反应监测。
- 共识关注LC-COPD的早期筛查和治疗选择,以及治疗期间的注意事项。
核心结论
- 共识强调对LC-COPD患者应同时治疗肺癌和COPD,同时注意两种疾病对治疗的相互影响并监测不良反应。
研究设计与样本
- 由肿瘤、呼吸、影像、介入和胸外科专家组成的小组制定,基于对LC-COPD现有证据的全面回顾,经讨论后以超过70%的投票同意率达成17条推荐。
诊断标准与关键数值
- 17条推荐中,发病机制相关2条,总体策略相关4条,COPD临床应用相关2条,肺癌临床应用相关9条。
- 推荐以超过70%的投票同意率达成。
临床应用与阅片要点
- 共识推荐对LC-COPD患者同时治疗肺癌和COPD。
- 共识推荐在治疗过程中注意两种疾病对治疗的相互影响并监测不良反应。
- 共识强调在LC-COPD管理中采用以患者为中心的个体化治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Lung cancer combined by chronic obstructive pulmonary disease (LC-COPD) is a common comorbidity and their interaction with each other poses significant clinical challenges. However, there is a lack of well-established consensus on the diagnosis and treatment of LC-COPD.
METHODS: A panel of experts, comprising specialists in oncology, respiratory medicine, radiology, interventional medicine, and thoracic surgery, was convened. The panel was presented with a comprehensive review of the current evidence pertaining to LC-COPD. After thorough discussions, the panel reached a consensus on 17 recommendations with over 70% agreement in voting to enhance the management of LC-COPD and optimize the care of these patients.
RESULTS: The 17 statements focused on pathogenic mechanisms (n=2), general strategies (n=4), and clinical application in COPD (n=2) and lung cancer (n=9) were developed and modified. These statements provide guidance on early screening and treatment selection of LC-COPD, the interplay of lung cancer and COPD on treatment, and considerations during treatment. This consensus also emphasizes patient-centered and personalized treatment in the management of LC-COPD.
CONCLUSIONS: The consensus highlights the need for concurrent treatment for both lung cancer and COPD in LC-COPD patients, while being mindful of the mutual influence of the two conditions on treatment and monitoring for adverse reactions.
引用
- Zhou C, Qin Y, Zhao W, et al. International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease. Transl Lung Cancer Res. 2023. PMID: 37691866. doi:10.21037/tlcr-23-339
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。